Headline News about AbbVie![]() ![]() ![]() ![]() ![]() ![]() ![]()
Where AbbVie Stands With Analysts
February 10, 2023
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Talk Markets
![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2023
February 10, 2023
Via Benzinga
![]()
AbbVie Beats On Q4 Earnings, Skyrizi Sales Grows 76%, Annual Guidance Lags Consensus
February 09, 2023
Via Benzinga
![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|